CCL3 and neuropathic pain: (IL-6: 1.2 ± 0.8 pg/ml in controls versus 2.5 ± 2.4 pg/ml in neuropathic pain, P = 0.064; IL-10: 3.56 ± 2.45 pg/ml in controls versus 3.69 ± 2.40 pg/ml in neuropathic pain, P = 0.84; IL-17: 3.53 ± 2.11 pg/ml in controls versus 4.29 ± 2.02 pg/ml in neuropathic pain, P = 0.23; MIP-1α: 17.2 ± 11.2 pg/ml in controls versus 28.4 ± 16.4 pg/ml in neuropathic pain, P = 0.022; IL-23: 0.9 ± 0.3 pg/ml in controls versus 1.2 ± 0.4 pg/ml in neuropathic pain, P = 0.022).